Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GSK2126458
Also known as: 2126458
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
Phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target
Phosphoinositide 3-kinase (PI3K)
Mechanism of Action
Phosphoinositide 3-kinase (PI3K) inhibitor
Latest Stage of Development
Phase I
Indication
Cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy